Decentrialz logo
  • HIPAA Compliant
  • ISO 27001 Certified
Find Trials
About UsContact
Become a Volunteer+1 877 705 1914

Status:

WITHDRAWN

Cancer and Mild Cognitive Impairment a Patient-Caregiver Behavioral Intervention

Lead Sponsor:

Duke University

Conditions:

Cancer

Cognitive Impairment

Eligibility:

All Genders

18-100 years

Phase:

NA

Brief Summary

The purpose of this study is to see whether programs that include both a patient and their spouse or a patient and family caregiver (known as a dyad) are helpful for families in which one member of th...

Eligibility Criteria

Inclusion

  • Inclusion Criteria:
  • Patient inclusion criteria include:
  • Patients with Stage I-IV breast, colon, rectal, or lung cancer (newly diagnosed within 6 months; age 65 or older.
  • Participants must be living at home (either in her/his own home).
  • Participants must be fluent in English and able to learn basic skills for using a tablet computer to conduct videoconference treatment sessions.
  • Exhibit Mild Cognitive Impairment.
  • Have an informal family caregiver.
  • Inclusion Criteria:
  • (Partner or family member) inclusion criteria include:
  • Caregivers are 18 older.
  • Be fluent in English and able to learn basic skills for using a tablet computer to conduct videoconference treatment sessions.
  • Either co-reside with the patient or spend at least 3-4 hours day caregiving.
  • Not exhibit cognitive impairment.
  • Exclusion Criteria for both patients and caregivers:
  • Participant has visual or hearing impairments that preclude participation.
  • Participant has dementia and do not have the capacity to participate.
  • Have a serious untreated psychiatric illness as documented in medical chart review.
  • The patient and the caregiver score less than a 3 on the National Comprehensive Cancer Network (NCCN) Distress Thermometer (DT) on a scale 0 to 10 to screen for distress.

Exclusion

    Key Trial Info

    Start Date :

    January 15 2022

    Trial Type :

    INTERVENTIONAL

    Allocation :

    ACTUAL

    End Date :

    November 30 2026

    Estimated Enrollment :

    Patients enrolled

    Trial Details

    Trial ID

    NCT04826315

    Start Date

    January 15 2022

    End Date

    November 30 2026

    Last Update

    January 19 2022

    Active Locations (1)

    Enter a location and click search to find clinical trials sorted by distance.

    Page 1 of 1 (1 locations)

    1

    Duke University

    Durham, North Carolina, United States, 27705